The International Society for Pharmacoepidemiology's Comments on the Core Recommendations in the Summary of the Heads of Medicines Agencies (HMA) - EMA Joint Big Data Task Force.

Clicks: 370
ID: 63073
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 6 articles by views in pharmacoepidemiology and drug safety

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract is not available for this article.
Login to Search Abstract
Reference Key
pottegrd2019thepharmacoepidemiology Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Pottegård, Anton;Klungel, Olaf;Winterstein, Almut;Huybrechts, Krista;Hallas, Jesper;Schneeweiss, Sebastian;Evans, Stephen;Bate, Andrew;Pont, Lisa;Trifirò, Gianluca;Smith, Meredith;Bourke, Alison;
Journal pharmacoepidemiology and drug safety
Year 2019
DOI
10.1002/pds.4911
URL
Keywords
total hip arthroplasty clinical effect enhanced recovery after surgery rehabilitation benefit

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.